Repligen RGEN
NASDAQ RGEN
$167.79 +1.27 (+0.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Repligen (RGEN) Net Income towards Common Stockholders (2009 - 2026)

Updated

Repligen's Net Income towards Common Stockholders was -$38.43 million in Q3 2026, compared with $14.91 million a year earlier.

Analysis

Repligen (RGEN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Repligen's Net Income towards Common Stockholders was -$11.8 million through Sep 30, 2026; for FY2025, it was $48.89 million.

  • Net Income towards Common Stockholders shows a five-year compound annual growth rate of -4.0% (FY2020 to FY2025).
  • In earlier years, Net Income towards Common Stockholders was -$25.51 million in FY2024, $35.6 million in FY2023 (-80.9%), $185.96 million in FY2022 (+45.0%) and $128.29 million in FY2021 (+114.1%).
  • The Q3 2026 figure marks the lowest quarterly Net Income towards Common Stockholders in data going back to Q2 2012.
  • Compared with a year earlier, Net Income towards Common Stockholders was higher in three of the last four quarters, with growth averaging 53.4%.
  • The best year-over-year quarter for Net Income towards Common Stockholders over five years was Q2 2025 (growth of 160.2%); the worst was Q1 2024 (a decline of 78.5%).
  • Per Business Quant data, RGEN's Net Income towards Common Stockholders in the three quarters before Q3 2026 was $5.01 million (Q2 2026), $8.33 million (Q1 2026) and $13.29 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 1.72 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 920.00 Mn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 1.24 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 522.80 Mn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 1.47 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 753.00 Mn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 582.00 Mn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 301.40 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 321.00 Mn
10 Repligen 9.51 Bn 6.29 Bn 110.99 Mn -38.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -38.43 Mn
Jun 30, 2026 5.01 Mn
Mar 31, 2026 8.33 Mn
Dec 31, 2025 13.29 Mn
Sep 30, 2025 14.91 Mn
Jun 30, 2025 14.87 Mn
Mar 31, 2025 5.83 Mn
Dec 31, 2024 -33.87 Mn
Sep 30, 2024 -654,000.00
Jun 30, 2024 5.71 Mn
Mar 31, 2024 3.30 Mn
Dec 31, 2023 -16.45 Mn
Sep 30, 2023 16.92 Mn
Jun 30, 2023 19.79 Mn
Mar 31, 2023 15.34 Mn
Dec 31, 2022 48.34 Mn
Sep 30, 2022 40.41 Mn
Jun 30, 2022 49.86 Mn
Mar 31, 2022 46.96 Mn
Dec 31, 2021 29.11 Mn
API Access

Repligen Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RGEN&period=max&api_key=YOUR_API_KEY